SINEDORE Trademark
Trademark Overview
On Wednesday, July 3, 2024, a trademark application was filed for SINEDORE with the United States Patent and Trademark Office. The USPTO has given the SINEDORE trademark a serial number of 98632503. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, April 15, 2025. This trademark is owned by Sinedore Medicine Inc.. The SINEDORE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Providing pharmaceutical and biomedical research and development; research and development of new products for others; technological research in the field of diagnostic, therapeutic, and pharmaceutical applications of medical reagents; scientific research; chemical research; Scientific and technological services, namely, scientific research and analysis in the field of medical reagents for diagnostic, therapeutic, and pharmaceutical applications, including development, testing, and validation; Pharmaceutical development
General Information
Serial Number | 98632503 |
Word Mark | SINEDORE |
Filing Date | Wednesday, July 3, 2024 |
Status | 686 - PUBLISHED FOR OPPOSITION |
Status Date | Tuesday, April 15, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | Tuesday, April 15, 2025 |
Trademark Statements
Description of Mark | The mark consists of a circle with the stylized word "SINEDORE" on the edge and an outline of a stylized face within the center of the circle that contains a short line and detached point that touches the top of the stylized face and a short line and detached point that touches the bottom of the stylized face. |
Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Goods and Services | Providing pharmaceutical and biomedical research and development; research and development of new products for others; technological research in the field of diagnostic, therapeutic, and pharmaceutical applications of medical reagents; scientific research; chemical research; Scientific and technological services, namely, scientific research and analysis in the field of medical reagents for diagnostic, therapeutic, and pharmaceutical applications, including development, testing, and validation; Pharmaceutical development |
Classification Information
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, July 3, 2024 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Sinedore Medicine Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Taipei TW |
Party Name | Sinedore Medicine Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Taipei TW |
Trademark Events
Event Date | Event Description |
Wednesday, July 3, 2024 | NEW APPLICATION ENTERED |
Monday, January 27, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Monday, January 27, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, February 4, 2025 | NON-FINAL ACTION WRITTEN |
Tuesday, February 4, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, March 19, 2025 | EXAMINERS AMENDMENT E-MAILED |
Wednesday, March 19, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Wednesday, March 19, 2025 | EXAMINERS AMENDMENT -WRITTEN |
Wednesday, March 19, 2025 | EXAMINER'S AMENDMENT ENTERED |
Wednesday, March 19, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Wednesday, April 9, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, April 15, 2025 | PUBLISHED FOR OPPOSITION |
Tuesday, April 15, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, February 4, 2025 | NON-FINAL ACTION E-MAILED |
Tuesday, January 28, 2025 | ASSIGNED TO EXAMINER |